BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 5112055)

  • 1. Aspartic acid in the treatment of chronic hepatitis.
    Fodor O; Barbarino F; Cotul S
    Acta Hepatosplenol; 1971; 18(5):383-94. PubMed ID: 5112055
    [No Abstract]   [Full Text] [Related]  

  • 2. [New data on the protective action of aspartic acid in experimental toxic hepatitis, assessed by the determination of blood and tissue enzymes of the liver].
    Fodor O; Parau N; Calu C; Ban A
    Rev Int Hepatol; 1965; 15(6):1131-46. PubMed ID: 5854655
    [No Abstract]   [Full Text] [Related]  

  • 3. [The anti-hepatotoxic effect of aliphatic and heterocyclic mercapto compounds in CCl4-induced liver damage in the rat. I].
    Rauen HM; Schriewer H; Fels H
    Arzneimittelforschung; 1973 Jan; 23():Suppl:136-40. PubMed ID: 4740680
    [No Abstract]   [Full Text] [Related]  

  • 4. [The anti-hepatotoxic effect of aliphatic and heterocyclic mercapto compounds in CCl4-induced liver damage in the rat. II].
    Rauen HM; Schriewer H; Fels H
    Arzneimittelforschung; 1973 Jan; 23():Suppl:141-5. PubMed ID: 4740681
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of B.S.P. metabolites and some histo-enzymologic modifications under the influence of aspartic acid].
    Barbarino F; Cotutiu C; Tapalaga D; Nicoara A
    Rev Int Hepatol; 1967 May; 17(6):491-504. PubMed ID: 4296788
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the therapy of liver diseases with ornithine aspartate].
    Melzer H; Weber D; Wotzka R
    Med Klin; 1969; 64(35):1541-4. PubMed ID: 5354488
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of essential phospholipids following acute experimental CCl4 liver injury].
    Rauen HM; Schriewer H; Gebauer B; Abu Tair M
    Arzneimittelforschung; 1973 Sep; 23(9):1332-4. PubMed ID: 4801231
    [No Abstract]   [Full Text] [Related]  

  • 8. [The antihepatotoxic effect of silymarin on liver damage in rats induced by carbon tetrachloride, d-galactosamine and allyl alcohol].
    Rauen HM; Schriewer H
    Arzneimittelforschung; 1971 Aug; 21(8):1194-201. PubMed ID: 5110018
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of cysteamine on carbon tetrachloride induced hepatic injury in rats].
    Ohta S; Kumasaka M; Shinoda M
    Yakugaku Zasshi; 1985 Sep; 105(9):866-73. PubMed ID: 4093869
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-hepatotoxic effects of root and root callus extracts of Cichorium intybus L.
    Zafar R; Mujahid Ali S
    J Ethnopharmacol; 1998 Dec; 63(3):227-31. PubMed ID: 10030727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental evaluation of the effectiveness of geriatric preparations].
    Zapadniuk VI; Kuprash LP; Strizhova-Salova NI; Zaika MU; Leliukh VM
    Farmakol Toksikol; 1972 Jul; 35(4):459-61. PubMed ID: 5050279
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of galbanic acid on the course of experimental hepatitis].
    Syrov VN; Khushbaktova ZA; Nabiev AN
    Farmakol Toksikol; 1990; 53(2):41-3. PubMed ID: 2369953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Silymarin action in liver diseases].
    Hammerl H; Pichler O; Studlar M
    Med Klin; 1971 Sep; 66(36):1204-8. PubMed ID: 5096207
    [No Abstract]   [Full Text] [Related]  

  • 14. [Correlations of enzyme activities in serum after experimental liver damage in rats].
    Rauen HM; Schriewer H
    Arzneimittelforschung; 1971 Aug; 21(8):1201-5. PubMed ID: 5110019
    [No Abstract]   [Full Text] [Related]  

  • 15. Early identification of carbon tetrachloride hepatotoxicity in albino rats.
    Said MM; Ibrahim MH; Mekkawy MY
    Pharmazie; 1984 Jan; 39(1):64-5. PubMed ID: 6718473
    [No Abstract]   [Full Text] [Related]  

  • 16. [Alkaline leukocyte phosphatase in the diagnosis of acute hepatitis].
    Boll I; Wujanz G
    Dtsch Med Wochenschr; 1969 Feb; 94(7):318-22. PubMed ID: 5762990
    [No Abstract]   [Full Text] [Related]  

  • 17. PHARMACOLOGICAL STUDY ON L-ORNITHINE L-ASPARTATE.
    SHIOYA A; KURAISHI K; KAKIMOTO M; TAMAMA Y
    Jpn J Pharmacol; 1964 Jun; 14():201-14. PubMed ID: 14215548
    [No Abstract]   [Full Text] [Related]  

  • 18. [Change in enzyme activity in experimental acute hepatic insufficiency].
    Lokshin LS; Pustovalova LM
    Eksp Khir Anesteziol; 1973; 18(3):40-2. PubMed ID: 4773559
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rifampicin pharmacokinetics in experimental hepatitis].
    Nazarova OI; Bobrov VI
    Antibiot Med Biotekhnol; 1987 Nov; 32(11):859-61. PubMed ID: 3439792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of the phenol compounds of Arnica in toxic lesion of the liver].
    Marchishin SM
    Farmakol Toksikol; 1983; 46(2):102-6. PubMed ID: 6852212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.